News

Science News2d
RSV wasn’t as hard on U.S. babies last winter. This may be why
Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.
Infectious Disease Advisor2d
RSV Vaccine in Older Adults: Single RSVPreF3 OA Dose Effective for 3 Seasons
A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.
Clinical Pain Advisor3d
RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization
Maternal RSV vaccination and nirsevimab were associated with a reduction in RSV hospitalization rates in infants aged 0 to 7 months during the 2024-2025 RSV season.
The American Journal of Managed Care4d
Infant RSV Hospitalization Rates Drop in First Season With Widespread Preventive Product Use
New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...
RSV vaccines and nirsevimab tied to reduced RSV-linked hospitalization
Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...